We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ADVANTECH SERVICE-IOT CO., LTD. TAIWAN BRAN

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Diagnostic Catheters Optimize Treatment of Heart Disease

By HospiMedica International staff writers
Posted on 28 Feb 2017
Print article
Image: The DxTerity system and DxTerity TRA diagnostic catheters (Photo courtesy of Medtronic).
Image: The DxTerity system and DxTerity TRA diagnostic catheters (Photo courtesy of Medtronic).
A new line of diagnostic angiography catheters and transradial-specific products advance diagnostic cardiac catheterization procedures and percutaneous coronary intervention (PCI).

The DxTerity and DxTerity transradial (TRA) diagnostic catheters are designed to determine whether or not revascularization is necessary in patients with coronary artery disease, with the DxTerity TRA catheters designed to allow engagement of both coronary arteries without catheter exchange. Also offered is the InTRAkit access kit, composed of ergonomic needles for flashback visualization, atraumatic mini-guidewires, and tapered introducer sheaths that provide kink resistance and enhanced lubricity for easy insertion.

The system includes the TRAcelet compression device to simplify pressure reduction following TRA catheterization by facilitating access site patent hemostasis, thus stopping bleeding while maintaining radial artery patency; and the Transradial Arc Curriculum, a fully-customizable education and training solution for physicians, hospital staff and administrators to ensure successful adoption of the TRA approach from access to patent hemostasis. The DxTerity system is a product of Medtronic.

“Our new line of comprehensive transradial products and programs that support PCI from start to finish were developed to meet the evolving clinical and health economic needs of physicians, administrators, and cath lab teams around the globe,” said Jason Weidman, of the cardiac and vascular group at Medtronic. “Our intent with these recent innovations in our premium product portfolio is to help accelerate adoption of the transradial approach, so that more patients and hospitals may experience the advantages transradial access can bring.”

“The global approval of the DxTerity diagnostic catheters, as well as the introduction of the new Medtronic suite of transradial products, represents a significant step forward for patients requiring PCI procedures,” said interventional cardiologist Sunil Rao, MD, of Duke University (Durham NC, USA; www.duke.edu). “It's increasingly important to have a full suite of products accompanied by robust training to increase physician utilization, improve patient comfort, and enable same-day discharge.”


Print article
Radcal

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.